XML 62 R47.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Compensation Expense and Related Tax Benefits
The following table presents compensation expense and related tax benefits for all equity awards recognized in the consolidated statements of income for the years ended December 31, 2023, 2022 and 2021:
202320222021
 (dollars in thousands)
Compensation expense$11,265 $15,081 $9,264 
Tax benefit(2,484)(2,690)(2,027)
Total stock-based compensation, net of tax $8,781 $12,391 $7,237 
Stock Option Activity
The following table provides information about stock option activity for the year ended December 31, 2023:
Stock
Options
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
(in millions)
Outstanding and exercisable as of December 31, 2022108,464 $12.11 
Granted— — 
Exercised(68,134)11.81 
Forfeited— — 
Expired(195)11.58 
Outstanding and exercisable as of December 31, 202340,135 $12.61 0.3 years$0.2 
Schedule Of Options Exercised
The following table presents information about stock options exercised for the years ended December 31, 2023, 2022 and 2021:
202320222021
 (dollars in thousands)
Number of options exercised68,134 130,503 148,670 
Total intrinsic value of options exercised$249 $842 $801 
Cash received from options exercised$805 $1,402 $1,651 
Tax benefit from options exercised$47 $163 $155 
Schedule of Nonvested Share Activity
The following table provides information about nonvested restricted stock, RSUs and PSUs granted under the Employee Equity Plan and Directors' Plan for the year ended December 31, 2023:
 
Restricted Stock/RSUs/PSUs(1)
 SharesWeighted
Average
Grant Date
Fair Value
Nonvested as of December 31, 20222,524,196 $14.16 
Granted1,026,492 11.85 
Vested(806,481)11.79 
Forfeited(81,736)13.21 
Nonvested as of December 31, 20232,662,471 $14.24 
(1) There were no nonvested stock options at December 31, 2023 or 2022.
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The fair value of certain PSUs with market-based performance conditions granted under the Employee Equity Plan was estimated on the grant date using the Monte Carlo valuation methodology performed by a third-party valuation expert. This valuation is dependent upon certain assumptions, as summarized in the following table:
202320222021
Risk-free interest rate3.84 %2.84 %0.25 %
Volatility of Corporation’s stock35.63 %43.46 %42.55 %
Expected life of PSUs3 years3 years3 years
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions The following table summarizes activity under the ESPP:
202320222021
ESPP shares purchased162,667 134,645 134,156 
Average purchase price per share (85% of market value)$11.68 $14.06 $13.92 
Compensation expense recognized (in thousands)$348 $334 $329